FANCG Polyclonal antibody

FANCG Polyclonal Antibody for IF, IP, WB,ELISA

Host / Isotype

Rabbit / IgG


human, mouse, rat





Cat no : 10215-1-AP


DNA repair protein XRCC9, FAG, FANCG, Fanconi anemia group G protein, Protein FACG, XRCC9

Tested Applications

Positive WB detected inJurkat cells, mouse testis tissue, K-562 cells, HeLa cells, mouse thymus tissue
Positive IP detected inmouse testis tissue
Positive IF detected inHeLa cells

Recommended dilution

Western Blot (WB)WB : 1:200-1:1000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for IP and 1:200-1:1000 for WB
Immunofluorescence (IF)IF : 1:10-1:100
Sample-dependent, check data in validation data gallery

Product Information

10215-1-AP targets FANCG in WB, IP, IF, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen FANCG fusion protein Ag0249
Full Name Fanconi anemia, complementation group G
Calculated molecular weight 69 kDa
Observed molecular weight 65-68 kDa
GenBank accession numberBC000032
Gene symbol FANCG
Gene ID (NCBI) 2189
Conjugate Unconjugated
Form Liquid
Purification Method Antigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

FANCG, also named as XRCC9, is a vDNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. It's a candidate tumor suppressor gene. FANCA and FANCG are critical for the localization of the FANC core complex. FANCA and FANCG form a stable complex with a molecular weight of ∼500 kDa that is predicted to be a heterotetramer (PMID: 32002546).


Product Specific Protocols
WB protocol for FANCG antibody 10215-1-APDownload protocol
IF protocol for FANCG antibody 10215-1-APDownload protocol
IP protocol for FANCG antibody 10215-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols



J Cancer

Significant value of XRCC2 and XRCC9 expression in the prognosis of human ovarian carcinoma.

Authors - Yi Liu

Clin Transl Oncol

Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study.

Authors - Yuzhong Cui